Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | 0.00% | 0.00% | +19,900.00% |
2023 | Cyren Ltd.(OTCPK:CYRN.Q) dropped from NASDAQ Composite Index | CI |
2023 | Top Premarket Decliners | MT |
Valuation
Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
Capitalization 1 | 84.21 | 124.6 | 162.5 | 75.93 | 62.75 | 26.4 |
Enterprise Value (EV) 1 | 73.59 | 100.6 | 154.9 | 83.5 | 84.55 | 40.92 |
P/E ratio | -13.4 x | -6.54 x | -8.29 x | -3.92 x | -3.6 x | -0.99 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 2.72 x | 4.05 x | 4.53 x | 1.98 x | 1.72 x | 0.85 x |
EV / Revenue | 2.38 x | 3.27 x | 4.31 x | 2.17 x | 2.32 x | 1.31 x |
EV / EBITDA | -67.4 x | -11.5 x | -11.7 x | -7.68 x | -8.57 x | -2.48 x |
EV / FCF | 119 x | -20.7 x | -18.5 x | -13.3 x | -27.1 x | -4.87 x |
FCF Yield | 0.84% | -4.84% | -5.41% | -7.51% | -3.69% | -20.5% |
Price to Book | 2.65 x | 2.83 x | 5.09 x | 3.08 x | 5.24 x | 1.92 x |
Nbr of stocks (in thousands) | 1,958 | 2,492 | 2,708 | 2,966 | 3,046 | 4,518 |
Reference price 2 | 43.00 | 50.00 | 60.00 | 25.60 | 20.60 | 5.844 |
Announcement Date | 4/27/17 | 4/27/18 | 3/28/19 | 3/30/20 | 3/30/21 | 3/24/22 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
Net sales 1 | 30.98 | 30.8 | 35.9 | 38.39 | 36.39 | 31.19 |
EBITDA 1 | -1.092 | -8.713 | -13.28 | -10.87 | -9.87 | -16.51 |
EBIT 1 | -5.174 | -13.76 | -19.3 | -16.34 | -15.04 | -21.59 |
Operating Margin | -16.7% | -44.68% | -53.76% | -42.58% | -41.34% | -69.23% |
Earnings before Tax (EBT) 1 | -6.215 | -15.69 | -19.57 | -18.13 | -17.38 | -23.18 |
Net income 1 | -6.213 | -15.65 | -19.41 | -18.02 | -17.26 | -23.04 |
Net margin | -20.05% | -50.81% | -54.08% | -46.93% | -47.44% | -73.87% |
EPS 2 | -3.200 | -7.648 | -7.239 | -6.532 | -5.723 | -5.895 |
Free Cash Flow 1 | 0.6188 | -4.869 | -8.386 | -6.271 | -3.119 | -8.396 |
FCF margin | 2% | -15.81% | -23.36% | -16.33% | -8.57% | -26.92% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 4/27/17 | 4/27/18 | 3/28/19 | 3/30/20 | 3/30/21 | 3/24/22 |
Balance Sheet Analysis
Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | 7.57 | 21.8 | 14.5 |
Net Cash position 1 | 10.6 | 24 | 7.57 | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | -0.6964 x | -2.209 x | -0.8793 x |
Free Cash Flow 1 | 0.62 | -4.87 | -8.39 | -6.27 | -3.12 | -8.4 |
ROE (net income / shareholders' equity) | -18% | -39.7% | -49.2% | -63.7% | -94% | -178% |
ROA (Net income/ Total Assets) | -6.34% | -15.4% | -19.4% | -16.9% | -15.7% | -25.7% |
Assets 1 | 97.93 | 101.7 | 99.99 | 106.6 | 110 | 89.7 |
Book Value Per Share 2 | 16.20 | 17.60 | 11.80 | 8.320 | 3.930 | 3.050 |
Cash Flow per Share 2 | 5.420 | 8.990 | 6.500 | 3.890 | 3.030 | 0.9500 |
Capex 1 | 0.99 | 1.77 | 3.32 | 1.47 | 1.77 | 0.52 |
Capex / Sales | 3.18% | 5.75% | 9.25% | 3.83% | 4.85% | 1.65% |
Announcement Date | 4/27/17 | 4/27/18 | 3/28/19 | 3/30/20 | 3/30/21 | 3/24/22 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+19,900.00% | 1.6K | |
-18.51% | 218B | |
-7.35% | 67.86B | |
-5.13% | 55.36B | |
-11.62% | 46.03B | |
+2.38% | 41.53B | |
-5.30% | 34.64B | |
-11.95% | 27.89B | |
+88.38% | 24.73B | |
+0.46% | 21.01B |
- Stock Market
- Equities
- CYRN.Q Stock
- Financials Cyren Ltd.